The U.S. Food and Drug Administration said on Friday it has approved AstraZeneca's nasal spray flu vaccine for ...

IDEAYA Biosciences is a promising biotech company targeting genetic vulnerabilities in cancer cells with synthetic lethality.

GSK PLC GSK shares slipped 2.45% to £15.36 Friday, on what proved to be an all-around grim trading session for the stock ...

The Atlanta-based beverage maker’s investment will support businesses in the value chain including distributors, retailers ...

Topline results were announced from a phase 3 study assessing the immune response following coadministration of Arexvy and Shingrix.

Mirvetuximab soravtansine was the first ADC to show efficacy as a therapy for platinum-resistant ovarian cancer. Despite high ...

Neuberg Diagnostics unveils 'Geniee', a personalised genomics platform offering genetic testing and tailored medicine for ...

Shields has been vocal about women's wellness and now backs an initiative for women to get protected against a viral ...

Data science is one of the most current career choices today, especially in a data-driven world. Today, more businesses rely on data for making strategic decisi ...

Obermair called for his fellow gynecological cancer surgeons to join him in interrogating current standards of practice.

Until recently, the pharmaceutical industry remained relatively insulated from the simmering trade war between China and the ...

Moderna should not be left off the list of interesting investment opportunities, as the company has one of the best pipelines ...